Drug Profile
Desvenlafaxine extended-release - RVL Pharmaceuticals
Alternative Names: Desvenlafaxine ER - RVL Pharmaceuticals ; KhedezlaLatest Information Update: 21 Jan 2022
Price :
$50
*
At a glance
- Originator Osmotica Pharmaceutical
- Developer RVL Pharmaceuticals
- Class Amines; Antidepressants; Cyclohexanols; Phenols; Small molecules
- Mechanism of Action Adrenergic uptake inhibitors; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Market Withdrawal Major depressive disorder